Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 25,677 | -19,040 | -9,266 | -60,477 | -42,842 |
| Depreciation Amortization | 661 | 661 | 661 | 3,354 | 2,685 |
| Accounts payable and accrued liabilities | 3,091 | 1,951 | 1,170 | -1,852 | -2,228 |
| Other Working Capital | -47,298 | -4,356 | -2,961 | -11,952 | -19,959 |
| Other Operating Activity | 3,806 | 4,813 | 329 | 11,010 | 10,779 |
| Operating Cash Flow | $-14,063 | $-15,971 | $-10,067 | $-59,917 | $-51,565 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 687 | 687 | 524 | -123 | -123 |
| Investing Cash Flow | $687 | $687 | $524 | $-123 | $-123 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -244 | -631 | -304 | -1,429 | -1,158 |
| Common Stock Issued | 5 | 5 | 5 | 2,396 | 2,419 |
| Other Financing Activity | -1,517 | 0 | -327 | -623 | -297 |
| Financing Cash Flow | $-1,756 | $-626 | $-626 | $344 | $964 |
| Beginning Cash Position | 17,909 | 17,909 | 17,909 | 77,605 | 77,605 |
| End Cash Position | 2,777 | 1,999 | 7,740 | 17,909 | 26,881 |
| Net Cash Flow | $-15,132 | $-15,910 | $-10,169 | $-59,696 | $-50,724 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,063 | -15,971 | -10,067 | -59,917 | -51,565 |
| Capital Expenditure | 0 | N/A | 0 | -123 | -123 |
| Free Cash Flow | -14,063 | -15,971 | -10,067 | -60,040 | -51,688 |